Evidence map›Paper›PMID 36274706›Full record

ArticleFrontiers in microbiology2022

Acceptor dependent catalytic properties of GH57 4-α-glucanotransferase from

Jong-Hyun Jung, Seungpyo Hong, Eun Jung Jeon, Min-Kyu Kim, Dong-Ho Seo, Eui-Jeon Woo, James F Holden, Cheon-Seok Park

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Jong-Hyun JungRadiation Research Division, Korea Atomic Energy Research Institute, Jeongeup, South Korea.
Seungpyo HongDepartment of Molecular Biology, Jeonbuk National University, Jeonju, South Korea.
Eun Jung JeonDepartment of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
Min-Kyu KimRadiation Research Division, Korea Atomic Energy Research Institute, Jeongeup, South Korea.
Dong-Ho SeoDepartment of Food Science and Technology, Jeonbuk National University, Jeonju, South Korea.
Eui-Jeon WooKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea.
James F HoldenDepartment of Microbiology, University of Messachusetts, Amherst, MA, United States.
Cheon-Seok ParkDepartment of Food Science and Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Yongin, South Korea.
Jeonbuk National University · KRKorea Atomic Energy Research Institute · KRKorea Advanced Institute of Science and Technology · KRKorea Research Institute of Bioscience and Biotechnology · KRKyung Hee University · KRUniversity of Massachusetts Amherst · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 4-α-glucanotransferase (4-α-GTase or amylomaltase) is an essential enzyme in maltodextrin metabolism. Generally, most bacterial 4-α-GTase is classified into glycoside hydrolase (GH) family 77. However, hyperthermophiles have unique 4-α-GTases belonging to GH family 57. These enzymes are the main amylolytic protein in hyperthermophiles, but their mode of action in maltooligosaccharide utilization is poorly understood. In the present study, we investigated the catalytic properties of 4-α-GTase from the hyperthermophile

Indexed as

4-α-glucanotransferaseacceptor binding sitedisproportionationglycoside hydrolase family 57hyperthermophilic archaeaPyrococcus

Identifiers

PMID36274706
PMCPMC9582752
OpenAlexW4302305113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.